Day November 19, 2025

Introduction Korea’s clinical‑trial ecosystem is quickly becoming a global hub. In 2026, triple‑agonist clinical trials in Korea will dominate metabolic research. The Ministry of Food and Drug Safety’s (MFDS) IND approval trends and regulatory reforms are accelerating these studies, and…